Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Genetic Disorders and Genomics
ROSA26: The ‘Safe Harbor’ Locus in the Mouse Genome
Cyagen Technical Content Team | June 01, 2025
Explore Ready-to-Use Mouse Models in MouseAtlas
Discover our extensive library of KO, cKO, and disease-specific mouse models. Accelerate your research with study-ready animals validated by scientists worldwide.
Explore Ready-to-Use Mouse Models in MouseAtlas
Contents
01. The Disadvantages of Random Integration 02. The Discovery of ROSA26 03. Classifications of ROSA26 Gene Knockin Models 04. The Applications of ROSA26

What is the first thing that comes to your mind when we mention ‘safe harbor’? The ‘safe harbor’ we want to talk about today is not the kind for ships, but, rather, the safe locus for targeted integration of exogenous gene in the mouse genome. Let's explore one of the most well-established safe loci in the mouse genome - ROSA26.

The Disadvantages of Random Integration

When using cell lines or model organisms to study gene function, we usually use a strategy called gain of function / loss of function to learn the specific functionality and regulatory mechanisms of target gene(s) in cells or animals. Gain of function is usually achieved by gene knockin (KI) techniques to promote over-expression of gene, while loss of function is usually achieved via gene knockout (KO). In this paper, we mainly discuss the KI, or over-expression model. Gene knockin (KI) refers to the technology of inserting exogenous functional genes or fragments into the genome by transgenic or homologous recombination technique, enabling their ability to function in the cell.

Due to the random integration of transferred genes in mice prepared by traditional transgenic technology, this leads to problems such as an uncertain copy number across integration sites, making it is necessary to screen the offspring for mice with stable protein expression. In addition, the phenotype of the first-generation-mice is easily to lost during passage due to reasons such as the dilution of copy number and the silencing of surrounding genes caused by the integration site – posing a significant inconvenience to the subsequent establishment of lines and repeated experiments.

Is there a site that allows for the stable, high-expression of a transferred gene and avoids affecting the expression of other genes nearby? To obtain mice with stable gene expression without screening, it is necessary to provide a reliable ‘safe harbor’ for the exogenous gene. Within these ‘safe harbors’, the exogenous gene(s) are stably and efficiently expressed, and cause no side effects on regular functionality of associated cells and tissues.

The Discovery of ROSA26

Researchers have tested numerous different gene insertion sites in the mouse genome and found a few special sites wherein it is very safe and stable to insert any DNA – the ROSA26 ‘safe harbor’ locus is included among these special sites. The identification of ROSA26 is probably one of the most exciting discoveries in the history of genetic engineering, and is regarded as one of the most important breakthroughs in the whole history of genetics.

ROSA26 was first discovered by Friedrich and Soriano when they studied gene mutations in mouse embryonic stem cells (ESCs). The ROSA26 locus is known in the scientific community by the official name: gene trap ROSA 26 [Gt(ROSA)26Sor]. ROSA26 is a non-coding gene composed of three exons on mouse chromosome-6, a region where it is easy to insert genes. There are no known functional proteins encoded by the ROSA26 gene. Additionally, the ROSA26 locus makes it easy to perform homologous recombination (HR), maintains expression levels of the protein from gene constructs inserted into this region, and does not affect the expression or function of other endogenous genes. Given its wide expression across all cell types and developmental stages, the ROSA26 region is often used as a safe site for gene targeting in mouse models.

Classifications of ROSA26 Gene Knockin Models

In general, there are three different types of ROSA26 locus knockin (KI):

  • The first type is the original version, wherein the cDNA of the knockin gene is controlled by the ROSA26 promoter and is constitutively expressed in vivo (Figure a). Specifically, the transgene of the splice acceptor (SA) sequence of the cDNA was inserted into the XbA1 restriction enzyme cutting site in the first intron of the ROSA26 gene. A stop cassette, which is consisted of neomycin-resistant gene (NeoR, Positive selective marker) and three polyadenylate (pA), was inserted upstream of the transgene.
  • The second strategy is conditional knockin (cKI), a variant of the first strategy which is achieved by inserting loxP sites on both sides of stop cassette (Figure b). In this case, the presence of the termination box can prevent the expression of the transgene. Upon mating with CRE expressing mice, the termination box sequence can be removed by homologous recombination (HR) in select tissues, depending on the type of CRE mouse strains used. However, the moderate strength of the natural ROSA26 promoter may not always achieve the desired transgenic expression levels.
  • In order to overcome the limitation of the natural ROSA26 promoter, the third strategy is to introduce an exogenous promoter or enhancer (such as CAG promoter) to drive high transgene expression (Figure c). In addition, an IRES-GFP box with FRT sites on both sides can be cloned in downstream of the transgene to visualize the expression of the transgene in vivo.
Source: Official website of Creative Biolabs
04 ASD disease models
Data from patients with ASD showed that the following genes all have mutations associated with the risk of ASD: neuroligin (NLGN3/4), neuronal cell surface proteins (NRXN1 and CNTNAP2), SH3 and multiple ankyrin repeat domains protein 3 (SHANK3), methyl-CpG-binding protein 2 (MECP2), fragile X messenger ribonucleoprotein 1 (FMR1), tuberous sclerosis complex (TSC1/2), CHD8, SCN2A, SYNGAP1, TBX1, ARID1B, GRIN2B, and TBR1;[5] but not every gene mutation will lead to development of ASD, the pathogenicity of each gene mutation needs sufficient experimental data to verify. In the past decades of research, researchers have constructed a number of autism or autism-like mice induced by deletion of ASD-related genes, which provides more animal models for ASD disease mechanism research, drug target discovery, and developing new treatment methods. The following are several major gene-edited autism mouse models, all of which are notably on C57BL/6J (a.k.a. B6, B6J) mouse strain background (which differs from the B/6N substrain).

Tbx1 Mice (E1-E2 knockout)

Large deletions of the human chromosome 22q11.2 locus can lead to ASD-like phenotypes, but the deletion region contains at least 30 genes, and the specific genes that lead to ASD phenotypes have yet to be identified. The study by Takeshi Hiramoto et al. in 2011 showed that among the more than 30 genes contained in the 22q11.2 large fragment deletion sequence, Tbx1 showed a high degree of correlation with developing ASD, and the heterozygous mice (HT) with Tbx1 single gene deletion showed an ASD-like phenotype with deficits in social interaction, and changes in memory-based behaviors, working memory, and developmental differences. [6]
Figure 1. Tbx1 heterozygous mice (HT) exhibited ASD-related behavioral phenotypes
left: frequencies and durations of vocalizations
right: T-maze spontaneous alternation behavior (SAB)[6]

Shank3B Mice (E13-E16 knockout)

Mutations in SHANK family genes are associated with syndromic and idiopathic forms of ASD, as well as other neuropsychiatric (e.g. schizophrenia) and neurodevelopmental disorders (e.g. intellectual disability). SHANK3 is a postsynaptic protein whose disruption at the genetic level is responsible for the development of 22q13 deletion syndrome and other non-syndromic ASDs. In a research paper published in Nature, João Peça describes that Shank3 gene-null mice exhibit defects in striatal synapses and cortico-striatal circuits, accompanied by self-injurious repetitive grooming and deficits in social interaction. This study revealed the key role of SHANK3 in the normal development of neuronal connections, and successfully uncovered the link between SHANK3 loss and autism-like behavior in mice.[7]
Figure 2. Shank3B-/- mice have reduced social interaction and abnormal social novelty recognition[7]

Cntnap2 Mice (E1 knockout)

CNTNAP2 encodes a neuronal transmembrane protein member of the Neurexin superfamily, which is involved in neuron-glial cell interaction and the accumulation of calcium channels in myelinated axons. Mutations in CNTNAP2 were originally shown to be associated with cortical dysplasia-focal epilepsy syndrome (CDFE), a rare disorder that causes seizures, language regression, intellectual disability, and hyperactivity. Simultaneously, nearly two-thirds of ASD-like phenotypes also exist in patients with CNTNAP2 mutations, and an increasing number of subsequent studies have demonstrated the link between this gene and the increased risk of autism or autism-related endophenotypes. Daniel H. Geschwind et al. have demonstrated that the knockout of the mouse Cntnap2 gene is closely related to ASD and related neurodevelopmental disorders in a research paper published in the journal Cell. Cntnap2-/- mice exhibit deficits in all three diagnostic symptoms of ASD, accompanied by hyperactivity and seizure phenotypes that are highly consistent with symptoms in patients with CNTNAP2 pathogenic variants,[8] making this one of the models that most fully represent the human ASD disease phenotype.
Figure 3. Cntnap2-/- mice exhibit an ASD phenotype with abnormal communication and social behavior[8]
05 Cyagen's Autism Research Mouse Model
Cyagen has thousands of self-developed gene-edited mouse strains, and can provide a series of mouse models related to autism research. The model information is detailed in the table below. At the same time, we can also provide professional customized services according to your project needs to accelerate your research.
Mouse Models of ASD
Gene Knockout Region Product Number Strain Name
TBX1 Exon3 S-CKO-17545 C57BL/6J-Tbx1em1(flox)Cya
SHANK3 Exon4-9 S-KO-11106 C57BL/6J-Shank3em1Cya
Exon13-16 S-KO-16224 C57BL/6J-Shank3em1Cya
Exon4-9 S-CKO-12419 C57BL/6J-Shank3em1(flox)Cya
Cntnap2 Exon3 S-KO-15901 C57BL/6J-Cntnap2em1Cya
Exon3 S-CKO-17468 C57BL/6J-Cntnap2em1(flox)Cya
The Cyagen Knockout Catalog Models repository can fully meet the project needs of basic research and new drug development, which provides off-the-shelf mouse models covering more than 20 research fields such as oncology, cardiovascular, and neurology. The powerful database offers you a more convenient experience for obtaining knockout mice on a 100% pure B6 background, with delivery in as fast as 2 weeks . Researchers can search our repository of over 16,000 KO/cKO mice to discover research models, compare data, and request a quote.
Subscribe to Receive Updates & Promotions From Cyagen
Subscribe
* Your privacy matters to us. We never share it with third parties.
Explore More
Y Maze Behavioral Task: Studying the function of spatial learning and memory in Neuroscience research
Spinocerebellar Ataxia Type III (SCA3) Research Model—B6-hATXN3 Mice
Vision Stolen by Years - Age-related Macular Degeneration
HFD+CCl4-Induced Metabolic Dysfunction-Associated Steatohepatitis (MASH/NASH) Mice
Share
Top
Ready to Elevate Your Research?
Discover how Cyagen can support your research. Let’s start a conversation.
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest